ADC Therapeutics SA (ADCT) Stock Analysis

Free AI-powered analysis and research for ADC Therapeutics SA stock

Sector: Healthcare

Analyze ADC Therapeutics SA (ADCT) Stock

ADC Therapeutics SA (ADCT) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ADCT stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for ADC Therapeutics SA stock.

📰 Latest Update

ADC Therapeutics (ADCT) Reports 2025 Revenue of $73.6M With Cash Runway Into 2028

Wed, March 18, 2026 at 9:31 PM UTC 4 min read

ADC Therapeutics (ADCT) reported a revenue of $73.6 million for 2025, indicating a strong financial performance. The company also confirmed a cash runway extending into 2028, which provides assurance to investors regarding its operational sustainability and ability to fund ongoing projects. This positive outlook may enhance investor confidence in ADCT's growth potential and strategic initiatives moving forward.

Read full article →

Why Analyze ADC Therapeutics SA (ADCT) with StockIQ?

• ✅ Free AI-powered analysis of ADC Therapeutics SA (ADCT) stock
• ✅ Real-time technical indicators for ADC Therapeutics SA stock
• ✅ Comprehensive risk assessment for ADCT
• ✅ No credit card required

People also watch